Published in Allergy on January 01, 1980
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut (2002) 1.45
Rapid modulation of N-formyl chemotactic peptide receptors on the surface of human granulocytes: formation of high-affinity ligand-receptor complexes in transient association with cytoskeleton. J Cell Biol (1984) 1.39
Lysosomal elastase and cathepsin G in beige mice. Neutrophils of beige (Chediak-Higashi) mice selectively lack lysosomal elastase and cathepsin G. J Exp Med (1986) 1.14
Characterization of the inhibitory prostanoid receptors on human neutrophils. Br J Pharmacol (1993) 1.02
Cartilage degradation by polymorphonuclear leucocytes: in vitro assessment of the pathogenic mechanisms. Ann Rheum Dis (1993) 1.00
Biosynthesis, transport and processing of myeloperoxidase in the human leukaemic promyelocytic cell line HL-60 and normal marrow cells. Biochem J (1984) 0.98
Conditioned medium from stimulated mononuclear leucocytes potentiates the ability of human neutrophils to damage human articular cartilage. Ann Rheum Dis (1988) 0.86
Inflammatory mechanisms in corneal ulceration. Trans Am Ophthalmol Soc (1985) 0.84
In vivo degradation of gonococcal outer membrane proteins within human leukocyte phagolysosomes. Infect Immun (1983) 0.84
Response of neutrophils to stimulus infusion: differential sensitivity of cytoskeletal activation and oxidant production. J Cell Biol (1988) 0.83
Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment. Ann R Coll Surg Engl (1990) 0.82
Ultrahistopathology of balanitis circinata. Br J Vener Dis (1982) 0.76
Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05
Metal chelate affinity chromatography, a new approach to protein fractionation. Nature (1975) 5.83
Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem (1978) 4.61
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med (2000) 4.35
Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis (1985) 3.77
Subcutaneous sterile water injections for chronic neck and shoulder pain following whiplash injuries. Lancet (1993) 3.63
Antibacterial activity of cationic proteins from human granulocytes. J Clin Invest (1975) 2.97
Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation (1996) 2.91
Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol (2001) 2.87
A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (1998) 2.85
An alloimmunized, thrombocytopenic patient successfully transfused with acid-treated, random-donor platelets. Br J Haematol (1991) 2.74
The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases. Eur J Biochem (1974) 2.65
Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature (1986) 2.41
Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood (1974) 2.22
Lipocalins as biochemical markers of disease. Biochim Biophys Acta (2000) 2.08
Mechanisms for the microbicidal activity of cationic proteins of human granulocytes. Infect Immun (1976) 2.05
Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy (2004) 2.03
The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases. Eur J Biochem (1973) 1.92
Retracted On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. J Clin Invest (1991) 1.89
Myeloperoxidase-mediated iodination in granulocytes. Scand J Haematol (1972) 1.83
Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature (1984) 1.75
Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med (1999) 1.69
Radioimmunoassay of human eosinophil cationic protein. Br J Haematol (1977) 1.68
Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. J Clin Invest (1990) 1.67
Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils. Blood (1987) 1.66
Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy (1993) 1.65
Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group. Eur Heart J (1997) 1.65
Tumor necrosis factor-induced degranulation in adherent human neutrophils is dependent on CD11b/CD18-integrin-triggered oscillations of cytosolic free Ca2+. Proc Natl Acad Sci U S A (1990) 1.60
Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med (2000) 1.58
Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest (1977) 1.57
Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest (1980) 1.56
The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung. Clin Exp Allergy (1999) 1.55
Altered density, metabolism and surface receptors of eosinophils in eosinophilia. Immunology (1982) 1.53
Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand J Clin Lab Invest (1995) 1.51
Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta (2011) 1.49
The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer. Br J Haematol (1997) 1.47
Granulocytes and their secretory products, myeloperoxidase and eosinophil cationic protein, in bronchoalveolar lavage fluids from two lung lobes in normal subjects. Eur Respir J (1991) 1.45
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut (2002) 1.45
Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Crit Care Med (1996) 1.44
Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol (1983) 1.43
A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol (1988) 1.43
Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro. Haematol Blood Transfus (1981) 1.42
Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein. Infect Immun (1976) 1.41
IL-5 priming of the PMA-induced oxidative metabolism of human eosinophils from allergic and normal subjects during a pollen season. Clin Exp Allergy (2001) 1.41
Activation of B-lymphocytes during pollen season. Effect of immunotherapy. Clin Exp Allergy (1998) 1.40
The Gordon phenomenon induced by the eosinophil cationic protein and eosinophil protein X. J Allergy Clin Immunol (1982) 1.40
Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coating. Ann Thorac Surg (1995) 1.40
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis (1993) 1.39
Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation. J Immunol (1989) 1.38
Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. Cancer Res (1983) 1.37
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol (1997) 1.37
Human eosinophil peroxidase: purification and characterization. J Immunol (1985) 1.36
Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine (1990) 1.35
Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol (1989) 1.32
Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis (1990) 1.31
Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res (1979) 1.30
Cationic proteins of human granulocytes. IV. Esterase activity. Lab Invest (1975) 1.28
Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol (1977) 1.25
Kinetic studies of phagocytosis. I. The serum independent particle uptake by PMN from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 1.24
Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest (1994) 1.23
Kinetic studies of phagocytosis of IgG-coated latex particles with a thrombocyte counter. J Lab Clin Med (1977) 1.22
The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis (1989) 1.21
Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro. Parasite Immunol (1981) 1.20
Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells. J Clin Pathol (1988) 1.20
Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma. Studies during inhalation challenge test. Allergy (1978) 1.19
Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med (2001) 1.18
Cytotoxicity for tumor cells of cationic proteins from human neutrophil granules. J Cell Biol (1976) 1.18
Isolation and characterization of glycosaminoglycans from human leukocytes and platelets. Biochim Biophys Acta (1967) 1.17
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol (1991) 1.17
Neutrophils from term and preterm newborn infants express the high affinity Fcgamma-receptor I (CD64) during bacterial infections. Pediatr Res (1999) 1.16
The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol (1988) 1.15
Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy (1991) 1.15
Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity. J Immunol (1975) 1.15
Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor. J Clin Invest (1986) 1.15
Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol (1990) 1.14
Isolation of human leukocyte granules using colloidal silica-polysaccharide density gradients. Exp Cell Res (1969) 1.13
Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors. Scand J Clin Lab Invest (1974) 1.13
Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis. Eur J Clin Microbiol Infect Dis (1995) 1.13
IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis. Dig Dis Sci (2001) 1.12
Studies on the phagocytic activity of the granulocytes in psoriasis and palmoplantar pustulosis. Br J Dermatol (1983) 1.11
Neutrophil and eosinophil granulocytes in bacterial infection: sequential studies of cellular and serum levels of granule proteins. Br J Haematol (1978) 1.11
Localization of chymotrypsin-like cationic protein, collagenase and elastase in azurophil granules of human neutrophilic polymorphonuclear leukocytes. Hoppe Seylers Z Physiol Chem (1977) 1.10
Nasal and ocular symptoms, tear film stability and biomarkers in nasal lavage, in relation to building-dampness and building design in hospitals. Int Arch Occup Environ Health (1999) 1.10
Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol (1996) 1.09
Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation (1990) 1.09
Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients. A comparison with Lyme disease. Acta Derm Venereol (1985) 1.09
Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein. DNA Cell Biol (1990) 1.08
Effects of serum and cations on the selective release of granular proteins from human netrophils during phagocytosis. Scand J Haematol (1979) 1.08